The real future of digital is in inclusion
Posted 23rd December 2011 in Articles, General | Register to comment
Ben Wagenaar shares his insights on why the future success of digital campaigns lies in bringing people together.
My Computer Science teacher at school once said that Information Technology was all about people. Every piece of hardware, every…
Read the full articleSix of the best: digital predictions for 2012 (part 1)
Posted 22nd December 2011 in Articles, General | Register to comment
Alex Butler shares the first of his digital predictions for the coming year, to be continued next week.
So what do you need to consider in your digital strategy for the coming year? Here are the first three of my six of the best predictions and top tips…
Read the full articleForever Jung: how early psychological theory is still relevant in patient consultations as well as internal marketing strategy
Posted 21st December 2011 in Articles, General | Register to comment
Matthew Hunt explores early psychological theory and applies it to current medical practice.
For numerous and frankly reassuring reasons, healthcare practice in the 21st century has distanced itself from the darker arts of…
Read the full articlePatient perspectives: Amy Tenderich
Posted 20th December 2011 in Articles, Devices & Diagnostics, Interviews, Therapeutic Area | Register to comment
As our Patient perspective series continues, we speak with Amy Tenderich on her experience as a diabetes patient and advocate and her ideas on where devices for diabetes should be heading.
Back in 2003 at the time of Amy’s diagnosis there was little in the way of online patient resources or online areas where patients …
Read the full articleCrikey, what a headache – pharmaceutical litigation, compensation and causation in Australia
Posted 20th December 2011 in Articles, General | Register to comment
Mabel Tsui discusses the progress to date of the Merck Sharp Dohme (Australia) Pty Ltd v Peterson case in Australia to date and how it highlights the need for tort law reform in Australia when it comes to pharmaceutical product litigation.
In October 2011, the Full Court of the Federal Court of Australia handed down their judgment in the case…
Read the full articleTunnah’s musings: why the drug industry is finished
Posted 19th December 2011 in Articles, General | 2 comments
In his latest musings Paul Tunnah thinks it’s time to draw a line under the drug industry, as it’s clearly got no future in the management of disease and delivery of health.
Last week I was surprised and, I have to admit, a little flattered to discover that I was the number one #pharmasuperfan, as determined by Silja Chouquet in…
Read the full articlePharma gets social: social mobile app helps Pfizer engage consumers in Israel
Posted 16th December 2011 in Articles | Register to comment
This month in ‘Pharma gets social’, Daniel Ghinn takes a look at Pfizer’s mobile health app for those with overactive bladders.
Social mobile app connects Pfizer with the right patients in the right place! There are no other emerging digital channels that capture the…
Read the full articlePharma and Facebook’s face off: why does the industry want to be on Facebook?
Posted 15th December 2011 in Articles, General | 1 comment
Darshan Kulkarni questions why the industry is so keen to be on Facebook and how explores how pharma can remain active on Facebook despite regulatory hurdles.
Facebook has 750 million active users. 50% of those active users log onto Facebook everyday. The average user has 130 friends. Individuals spend over…
Read the full articleMedia perspectives: Ed Silverman
Posted 14th December 2011 in Articles, Interviews | Register to comment
Kicking off the start of a new series where we speak with key media figures in pharma and healthcare, pharmaphorum caught up with Ed Silverman, the Editor of Pharmalot.
There’s never a dull moment in pharma, with every day bringing new breaking stories covering everything from updates on development and…
Read the full articleWhere to now for UK life sciences?
Posted 13th December 2011 in Articles, General | Register to comment
The 2012 UK Life Science Industry Leaders Survey highlights a concern that the UK is losing its position as a centre for global R&D. Nick Stephens presents results from the survey and draws out some themes that are relevant to the industry as a whole.
The 2012 UK Life Science Industry Leaders Survey highlights a concern that the UK is losing its position as a centre for global R&D…
Read the full article